BKD
Price
$10.37
Change
-$0.07 (-0.67%)
Updated
Nov 3, 04:59 PM (EDT)
Capitalization
2.49B
2 days until earnings call
Intraday BUY SELL Signals
SNDA
Price
$34.06
Change
+$0.19 (+0.56%)
Updated
Nov 3, 04:59 PM (EDT)
Capitalization
1.63B
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BKD vs SNDA

BKD vs SNDA Comparison Chart in %
View a ticker or compare two or three
VS
BKD vs. SNDA commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKD is a Buy and SNDA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BKD with price predictions
Nov 03, 2026

BKD in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 09, 2026

BKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 42 cases where BKD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BKD's RSI Indicator exited the oversold zone, 24 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on BKD as a result. In 70 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for BKD just turned positive on October 21, 2026. Looking at past instances where BKD's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.

Following a +1.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where BKD advanced for three days, in 228 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BKD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for BKD entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-86.048) is normal, around the industry mean (204.016). P/E Ratio (-17.695) is within average values for comparable stocks, (19.314). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (2.498). Dividend Yield (0.096) settles around the average of (0.094) among similar stocks. P/S Ratio (0.916) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. BKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 63 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for SNDA with price predictions
Nov 03, 2026

SNDA's RSI Oscillator climbs out of oversold territory

The RSI Indicator for SNDA moved out of oversold territory on October 28, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 22 of the 25 cases the stock moved higher. This puts the odds of a move higher at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 65 cases where SNDA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for SNDA just turned positive on October 30, 2026. Looking at past instances where SNDA's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.

Following a +2.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNDA advanced for three days, in 201 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

SNDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for SNDA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. SNDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.889) is normal, around the industry mean (204.016). P/E Ratio (-5.974) is within average values for comparable stocks, (19.314). SNDA's Projected Growth (PEG Ratio) (16.640) is very high in comparison to the industry average of (2.498). Dividend Yield (0.000) settles around the average of (0.094) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (2.688).

The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
BKD vs SNDA: Fundamental Ratings
BKD
SNDA
OUTLOOK RATING
1..100
127
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
6395
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6259
P/E GROWTH RATING
1..100
1626
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BKD's Valuation (5) in the Hospital Or Nursing Management industry is significantly better than the same rating for SNDA (95). This means that BKD’s stock grew significantly faster than SNDA’s over the last 12 months.

BKD's Profit vs Risk Rating (63) in the Hospital Or Nursing Management industry is in the same range as SNDA (95). This means that BKD’s stock grew similarly to SNDA’s over the last 12 months.

SNDA's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as BKD (100). This means that SNDA’s stock grew similarly to BKD’s over the last 12 months.

SNDA's Price Growth Rating (59) in the Hospital Or Nursing Management industry is in the same range as BKD (62). This means that SNDA’s stock grew similarly to BKD’s over the last 12 months.

BKD's P/E Growth Rating (16) in the Hospital Or Nursing Management industry is in the same range as SNDA (26). This means that BKD’s stock grew similarly to SNDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BKDSNDA
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 5 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 8 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
63%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (BKD: $10.37 vs. SNDA: $34.04)
Brand notoriety: BKD and SNDA are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: BKD: 99% vs. SNDA: 89%
Market capitalization -- BKD: $2.49B vs. SNDA: $1.63B
BKD [@Hospital/Nursing Management] is valued at $2.49B. SNDA’s [@Hospital/Nursing Management] market capitalization is $1.63B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $101.26B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BKD’s FA Score shows that 2 FA rating(s) are green while SNDA’s FA Score has 1 green FA rating(s).

  • BKD’s FA Score: 2 green, 3 red.
  • SNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, BKD is a better buy in the long-term than SNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BKD’s TA Score shows that 5 TA indicator(s) are bullish while SNDA’s TA Score has 5 bullish TA indicator(s).

  • BKD’s TA Score: 5 bullish, 3 bearish.
  • SNDA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SNDA is a better buy in the short-term than BKD.

Price Growth

BKD (@Hospital/Nursing Management) experienced а +8.81% price change this week, while SNDA (@Hospital/Nursing Management) price change was +3.78% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.48%. For the same industry, the average monthly price growth was +2.49%, and the average quarterly price growth was +11.67%.

Reported Earning Dates

BKD is expected to report earnings on Nov 06, 2026.

SNDA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-0.48% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
BKD
Daily Signal:
Gain/Loss:
SNDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BKD has been loosely correlated with SNDA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BKD jumps, then SNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BKD
1D Price
Change %
BKD100%
-0.67%
SNDA - BKD
42%
Loosely correlated
+0.50%
THC - BKD
25%
Poorly correlated
-0.82%
AGL - BKD
24%
Poorly correlated
+1.34%
AVAH - BKD
24%
Poorly correlated
+1.22%
CMPS - BKD
24%
Poorly correlated
+2.14%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FAZ32.340.60
+1.89%
Direxion Daily Financial Bear 3X ETF (FAZ)
FMF51.540.32
+0.62%
First Trust Managed Futures Strategy Fund (FMF)
PJUL49.510.11
+0.22%
Innovator U.S. Equity Power Buffer ETF - July (PJUL)
SAPH43.39-0.54
-1.22%
SAP SE ADRHEDGED
PEZ99.74-1.36
-1.34%
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF (PEZ)